2011 ASH Program Book - American Society of Hypertension
2011 ASH Program Book - American Society of Hypertension
2011 ASH Program Book - American Society of Hypertension
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Sunday Morning MAY 22<br />
Posters<br />
PO-137:<br />
PO-138:<br />
PO-139:<br />
PO-140:<br />
PO-141:<br />
Better Control <strong>of</strong> Central Pressures and Total<br />
Hypertensive Time in Patients with <strong>Hypertension</strong><br />
Receiving Telmisartan as Monotheraphy. Prospective<br />
Study<br />
Ricardo M. Cabrera Sole, 1 Caridad Turpin Lucas, 1<br />
Santiago Garcia Ruiz, 1 Rafael Fernandez, 2 Erik<br />
Luepke. 3 1 University General Hospital <strong>of</strong> Albacete,<br />
Albacete, ES; 2 Health Center <strong>of</strong> Villarrobledo,<br />
Albacete, ES; 3 University General Hospital “La Paz”,<br />
Madrid, ES.<br />
Intravenous Hydralazine for Blood Pressure<br />
Management in the Hospitalized Patient<br />
Patrick T. Campbell, William L. Baker, Bendel D.<br />
Steven, William B. White. University <strong>of</strong> Connecticut<br />
School <strong>of</strong> Medicine, Farmington, CT, US.<br />
Long-Term Efficacy and Safety <strong>of</strong> Combination<br />
Olmesartan Medoxomil/Amlodipine<br />
Besylate+Hydrochlorothiazide in Study Participants<br />
with <strong>Hypertension</strong> Based on Age: The TRINITY<br />
Study<br />
Steven G. Chrysant†, 1 Dean J. Kereiakes, 2 Suzanne<br />
Oparil, 3 Joseph Izzo, 4 Thomas Littlejohn, 5 Michael<br />
Melino, 6 James Lee, 6 Victor Fernandez, 6 Reinilde<br />
Heyrman. 6 1 Oklahoma Cardiovascular and<br />
<strong>Hypertension</strong> Center and University <strong>of</strong> Oklahoma<br />
College <strong>of</strong> Medicine, US; 2 The Christ Hospital Heart<br />
and Vascular Center and The Carl and Edyth Lindner<br />
Center for Research and Education at the Christ<br />
Hospital, US; 3 University <strong>of</strong> Alabama at Birmingham,<br />
US; 4 State University <strong>of</strong> New York at Buffalo, US;<br />
5 Piedmont Medical Research Associates, US; 6 Daiichi<br />
Sankyo, Inc, US.<br />
Long-Term Efficacy and Safety <strong>of</strong> Combination<br />
Olmesartan Medoxomil/Amlodipine<br />
Besylate+Hydrochlorothiazide—The TRINITY<br />
Study: A Subgroup Analysis by Study Participant<br />
Race<br />
Steven G. Chrysant†, 1 Dean J. Kereiakes, 2 Joseph Izzo, 3<br />
Thomas Littlejohn, 4 Suzanne Oparil, 5 Michael Melino, 6<br />
James Lee, 6 Victor Fernandez, 6 Reinilde Heyrman. 6<br />
1 Oklahoma Cardiovascular and <strong>Hypertension</strong> Center<br />
and University <strong>of</strong> Oklahoma College <strong>of</strong> Medicine, US;<br />
2 The Christ Hospital Heart and Vascular Center and<br />
The Carl and Edyth Lindner Center for Research and<br />
Education at the Christ Hospital, US; 3 State University<br />
<strong>of</strong> New York at Buffalo, US; 4 Piedmont Medical<br />
Research Associates, US; 5 University <strong>of</strong> Alabama at<br />
Birmingham, US; 6 Daiichi Sankyo, Inc, US.<br />
Comparison <strong>of</strong> Valsartan/Amlodipine Added to<br />
Diuretic with Losartan Added to Diuretic on BP<br />
Load in <strong>Hypertension</strong><br />
Daniel Duprez†, 1 Keith Ferdinand, 2 Das Purkayastha, 3<br />
Rita Samuel, 3 Richard F. Wright. 4 1 University <strong>of</strong><br />
Minnesota, Minneapolis, MN, US; 2 Emory University,<br />
Atlanta, GA, US; 3 Novartis Pharmaceuticals<br />
Corporation, East Hanover, NJ, US; 4 Pacific Heart<br />
Insitute, Santa Monica, CA, US.<br />
109